
[WSJ] After an Israeli biotech company stopped working on a promising medication, two U.S. families took an unusual step: They bought the drug and decided to develop it themselves as a possible treatment for their children's muscular dystrophy.
The Secklers, of Stockbridge, Mass., and the Wicka family, from Minneapolis, are hoping ...